4D Molecular Therapeutics — Fact Sheet (September 2023)

2 slides from 4D Molecular Therapeutics's fact sheet, Sep 22, 2023

Slide 1: Study 4D-710-C001: Phase 1/2 gene therapy trial in cystic fibrosis
Study 4D-710-C001 is a Phase 1/2 gene therapy clinical trial sponsored by 4D Molecular Therapeutics, Inc. called 4D-710 in adults with cystic fibrosis lung disease. WHY IS THE STUDY BEING CONDUCTED? WHO CAN PARTICIPATE? ABOUT THE STUDY The purpose of the study is to see You may be eligible to partic
Slide 2: Study 4D-710-C001 visit schedule
Icon key STUDY 4D-710-C001 In-person clinic visit STUDY VISIT SCHEDULE Phone visit This chart shows you the length of the study and how many study visits will take place in the clinic or by phone. SCREENING 4D-710 GIVEN OBSERVATION PERIOD LONG-TERM FOLLOW-UP PERIOD VISIT Day 2 (depending Month Month